GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procter & Gamble Health Ltd (NSE:PGHL) » Definitions » E10

Procter & Gamble Health (NSE:PGHL) E10 : ₹171.16 (As of Dec. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Procter & Gamble Health E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Procter & Gamble Health's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹54.760. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹171.16 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Procter & Gamble Health's average E10 Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-24), Procter & Gamble Health's current stock price is ₹5503.35. Procter & Gamble Health's E10 for the quarter that ended in Dec. 2024 was ₹171.16. Procter & Gamble Health's Shiller PE Ratio of today is 32.15.

During the past 13 years, the highest Shiller PE Ratio of Procter & Gamble Health was 45.44. The lowest was 28.13. And the median was 32.52.


Procter & Gamble Health E10 Historical Data

The historical data trend for Procter & Gamble Health's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procter & Gamble Health E10 Chart

Procter & Gamble Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Jun21 Jun22 Jun23 Jun24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 136.02 149.04 161.94

Procter & Gamble Health Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 156.54 158.56 161.94 166.85 171.16

Competitive Comparison of Procter & Gamble Health's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Procter & Gamble Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Procter & Gamble Health's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procter & Gamble Health's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Procter & Gamble Health's Shiller PE Ratio falls into.



Procter & Gamble Health E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Procter & Gamble Health's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=54.76/158.3229*158.3229
=54.760

Current CPI (Dec. 2024) = 158.3229.

Procter & Gamble Health Quarterly Data

per share eps CPI Adj_EPS
201412 0.610 96.780 0.998
201503 5.800 97.163 9.451
201506 10.160 99.841 16.111
201509 7.540 101.753 11.732
201512 8.780 102.901 13.509
201603 5.060 102.518 7.814
201606 13.720 105.961 20.500
201609 17.170 105.961 25.655
201612 11.710 105.196 17.624
201703 8.930 105.196 13.440
201706 12.120 107.109 17.915
201709 19.090 109.021 27.723
201712 16.430 109.404 23.777
201803 13.680 109.786 19.728
201806 29.100 111.317 41.388
201809 31.530 115.142 43.355
201812 430.940 115.142 592.553
201903 24.520 118.202 32.843
201906 26.560 120.880 34.787
201909 21.540 123.175 27.686
202003 27.990 124.705 35.535
202006 29.400 127.000 36.651
202009 35.700 130.118 43.439
202012 40.900 130.889 49.472
202103 9.500 131.771 11.414
202106 20.900 134.084 24.678
202109 33.400 135.847 38.926
202112 27.000 138.161 30.940
202203 30.800 138.822 35.127
202206 24.780 142.347 27.561
202209 38.300 144.661 41.917
202212 46.300 145.763 50.290
202303 35.700 146.865 38.485
202306 17.700 150.280 18.647
202309 39.500 151.492 41.281
202312 43.420 152.924 44.953
202403 28.000 153.035 28.968
202406 10.000 155.789 10.163
202409 49.600 157.882 49.738
202412 54.760 158.323 54.760

Add all the adjusted EPS together and divide 10 will get our e10.


Procter & Gamble Health  (NSE:PGHL) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Procter & Gamble Health's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=5503.35/171.16
=32.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Procter & Gamble Health was 45.44. The lowest was 28.13. And the median was 32.52.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Procter & Gamble Health E10 Related Terms

Thank you for viewing the detailed overview of Procter & Gamble Health's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Procter & Gamble Health Business Description

Traded in Other Exchanges
Address
Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.